B
STML
Bailard’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-64,600
| Closed | -$717K | – | 453 |
|
|
2017
Q3 | $717K | Sell |
64,600
-19,185
| -23% | -$213K | 0.06% | 190 |
|
|
2017
Q2 | $771K | Sell |
83,785
-55,000
| -40% | -$506K | 0.06% | 186 |
|
|
2017
Q1 | $1.19M | Buy |
138,785
+15,000
| +12% | +$128K | 0.1% | 162 |
|
|
2016
Q4 | $1.32M | Buy |
123,785
+29,000
| +31% | +$310K | 0.12% | 142 |
|
|
2016
Q3 | $1.03M | Hold |
94,785
| – | – | 0.09% | 163 |
|
|
2016
Q2 | $642K | Hold |
94,785
| – | – | 0.08% | 184 |
|
|
2016
Q1 | $442K | Buy |
+94,785
| New | +$442K | 0.06% | 161 |
|
|
2015
Q4 | – | Sell |
-64,785
| Closed | -$572K | – | 383 |
|
|
2015
Q3 | $572K | Buy |
64,785
+14,785
| +30% | +$131K | 0.09% | 132 |
|
|
2015
Q2 | $589K | Hold |
50,000
| – | – | 0.09% | 134 |
|
|
2015
Q1 | $724K | Buy |
+50,000
| New | +$724K | 0.1% | 125 |
|